These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 3102260

  • 1. Failure to detect 6-hydroxydopamine in rat striatum after the dopamine releasing drugs dexamphetamine, methylamphetamine and MPTP.
    Rollema H, De Vries JB, Westerink BH, Van Putten FM, Horn AS.
    Eur J Pharmacol; 1986 Dec 02; 132(1):65-9. PubMed ID: 3102260
    [Abstract] [Full Text] [Related]

  • 2. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ, Heavens RP, McBride CS.
    Brain Res; 1988 Mar 08; 443(1-2):101-16. PubMed ID: 3258784
    [Abstract] [Full Text] [Related]

  • 3. Comparison of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium (MPP+) effects on mouse heart norepinephrine.
    Fuller RW, Hemrick-Luecke SK, Robertson DW.
    Biochem Pharmacol; 1988 Sep 01; 37(17):3343-7. PubMed ID: 3135812
    [Abstract] [Full Text] [Related]

  • 4. The mechanism of action of MPTP and MPP+ on endogenous dopamine release from the rat corpus striatum superfused in vitro.
    Chang GD, Ramirez VD.
    Brain Res; 1986 Mar 12; 368(1):134-40. PubMed ID: 3485463
    [Abstract] [Full Text] [Related]

  • 5. The neurotoxic actions of 6-hydroxydopamine infused into the rat substantia nigra.
    Bradbury AJ, Costall B, Domeney AM, Jenner PJ, Marsden CD, Naylor RJ.
    Neurosci Lett; 1986 Jun 18; 67(2):208-12. PubMed ID: 2425303
    [Abstract] [Full Text] [Related]

  • 6. Effects on dopamine metabolism of MPTP and MPP+ infused through a push-pull cannula into the caudate nucleus of awake adult male rats.
    Chang GD, Ramirez VD.
    Brain Res; 1987 Oct 20; 424(1):49-57. PubMed ID: 3319041
    [Abstract] [Full Text] [Related]

  • 7. Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethylamine transport.
    Mayer RA, Kindt MV, Heikkila RE.
    J Neurochem; 1986 Oct 20; 47(4):1073-9. PubMed ID: 3489072
    [Abstract] [Full Text] [Related]

  • 8. Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse.
    Perry TL, Yong VW, Jones K, Wall RA, Clavier RM, Foulks JG, Wright JM.
    Neurosci Lett; 1985 Aug 05; 58(3):321-6. PubMed ID: 3876525
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. MPP+-induced increases in extracellular potassium ion activity in rat striatal slices suggest that consequences of MPP+ neurotoxicity are spread beyond dopaminergic terminals.
    Hollinden GE, Sanchez-Ramos JR, Sick TJ, Rosenthal M.
    Brain Res; 1988 Dec 20; 475(2):283-90. PubMed ID: 3265070
    [Abstract] [Full Text] [Related]

  • 11. 4-Phenylpyridine (4PP) and MPTP: the relationship between striatal MPP+ concentrations and neurotoxicity.
    Irwin I, Langston JW, DeLanney LE.
    Life Sci; 1987 Feb 23; 40(8):731-40. PubMed ID: 3492652
    [Abstract] [Full Text] [Related]

  • 12. Behavioral and biochemical changes following acute administration of MPTP and MPP+.
    Tadano T, Satoh N, Sakuma I, Matsumura T, Kisara K, Arai Y, Kinemuchi H.
    Life Sci; 1987 Mar 30; 40(13):1309-18. PubMed ID: 2436017
    [Abstract] [Full Text] [Related]

  • 13. Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium.
    Vyas I, Heikkila RE, Nicklas WJ.
    J Neurochem; 1986 May 30; 46(5):1501-7. PubMed ID: 3485701
    [Abstract] [Full Text] [Related]

  • 14. Serotonergic conversion of MPTP and dopaminergic accumulation of MPP+.
    Shen RS, Abell CW, Gessner W, Brossi A.
    FEBS Lett; 1985 Sep 23; 189(2):225-30. PubMed ID: 3876242
    [Abstract] [Full Text] [Related]

  • 15. Intracerebral microdialysis neurotoxicity studies of quinoline and isoquinoline derivatives related to MPTP/MPP+.
    Booth RG, Castagnoli N, Rollema H.
    Neurosci Lett; 1989 May 22; 100(1-3):306-12. PubMed ID: 2788253
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of tyrosine hydroxylation in rat striatal tissue slices by 1-methyl-4-phenylpyridinium ion.
    Hirata Y, Nagatsu T.
    Neurosci Lett; 1985 Jun 24; 57(3):301-5. PubMed ID: 3929190
    [Abstract] [Full Text] [Related]

  • 17. Acute effects of 1-methyl-4-phenylpyridinium ion (MPP+) on dopamine and serotonin metabolism in rat striatum as assayed in vivo by a micro-dialysis technique.
    Ozaki N, Nakahara D, Kaneda N, Kiuchi K, Okada T, Kasahara Y, Nagatsu T.
    J Neural Transm; 1987 Jun 24; 70(3-4):241-50. PubMed ID: 3500274
    [Abstract] [Full Text] [Related]

  • 18. Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
    Heikkila RE, Nicklas WJ, Vyas I, Duvoisin RC.
    Neurosci Lett; 1985 Dec 18; 62(3):389-94. PubMed ID: 3912685
    [Abstract] [Full Text] [Related]

  • 19. N-methyl-4-phenylpyridine (MMP+) together with 6-hydroxydopamine or dopamine stimulates Ca2+ release from mitochondria.
    Frei B, Richter C.
    FEBS Lett; 1986 Mar 17; 198(1):99-102. PubMed ID: 3082673
    [Abstract] [Full Text] [Related]

  • 20. Kinetics of [3H]MPP+ uptake in dopaminergic neurons of mouse: regional effects of MPTP neurotoxicity.
    Sershen H, Mason MF, Debler EA, Lajtha A.
    Eur J Pharmacol; 1986 Jul 31; 126(3):337-9. PubMed ID: 3489627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.